CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma

Multiple myeloma (MM) is a B cell neoplasia characterized by clonal plasma cell (PC) proliferation. Minimal residual disease monitoring by multi-parameter flow cytometry is a powerful tool for predicting treatment efficacy and MM outcome. In this study, we compared CD antigens expression between nor...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Alaterre, Elina, Raimbault, Sebastien, Goldschmidt, Hartmut, Bouhya, Salahedine, Requirand, Guilhem, Robert, Nicolas, Boireau, Stéphanie, Seckinger, Anja, Hose, Dirk, Klein, Bernard, Moreaux, Jérôme
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716778/
https://ncbi.nlm.nih.gov/pubmed/29228738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22131
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia